Cargando…

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis

Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Longfei, Cao, Zhangjun, Wang, Qi, Fang, Lu, Yan, Songbai, Xia, Dian, Wang, Jinyou, Bi, Liangkuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606658/
https://www.ncbi.nlm.nih.gov/pubmed/36313709
http://dx.doi.org/10.3389/fonc.2022.963483
_version_ 1784818344309817344
author Peng, Longfei
Cao, Zhangjun
Wang, Qi
Fang, Lu
Yan, Songbai
Xia, Dian
Wang, Jinyou
Bi, Liangkuan
author_facet Peng, Longfei
Cao, Zhangjun
Wang, Qi
Fang, Lu
Yan, Songbai
Xia, Dian
Wang, Jinyou
Bi, Liangkuan
author_sort Peng, Longfei
collection PubMed
description Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order to identify the candidate genes that may exist in the occurrence and development of ccRCC, microarray datasets GSE6344, GSE16441, GSE36895, GSE53757 and GSE76351 had been downloaded from Gene Expression Omnibus (GEO) database. Apart from that, the differentially expressed genes (DEGs) were screened through Bioinformatics & Evolutionary Genomics. In addition, the protein-protein interaction network (PPI) was constructed, and the module analysis was performed using STRING and Cytoscape. By virtue of DAVID online database, GO/KEGG enrichment analysis of DEGs was performed. Consequently, a total of 118 DEGs were screened, including 24 up-regulated genes and 94 down-regulated genes. The plug-in MCODE of Cytoscape was adopted to analyze the most significant modules of DEGs. What’s more, the genes with degree greater than 10 in DEGs were selected as the hub genes. The overall survival (OS) and disease progression free survival (DFS) of 9 hub genes were analyzed through GEPIA2 online platform. As shown by the survival analysis, SLC34A1, SLC12A3, SLC12A1, PLG, and ENO2 were closely related to the OS of ccRCC, whereas SLC34A1 and LOX were closely related to DFS. Among 11 SLC members, 6 SLC members were highly expressed in non-cancerous tissues (SLC5A2, SLC12A1, SLC12A3, SLC34A1, SLC34A2, SLC34A3). Besides, SLC12A5 and SLC12A7 were highly expressed in ccRCC. Furthermore, SLC12A1-A7, SLC34A1 and SLC34A3 were closely related to OS, whereas SLC12A2/A4/A6/A7 and SLC34A1/A3 were closely related to DFS. In addition, 5 algorithms were used to analyze hub genes, the overlapping genes were AQP2 and KCNJ1. To sum up, hub gene can help us understand the molecular mechanism of the occurrence and development of ccRCC, thereby providing a theoretical basis for the diagnosis and targeted therapy of ccRCC.
format Online
Article
Text
id pubmed-9606658
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96066582022-10-28 Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis Peng, Longfei Cao, Zhangjun Wang, Qi Fang, Lu Yan, Songbai Xia, Dian Wang, Jinyou Bi, Liangkuan Front Oncol Oncology Renal cell carcinoma (RCC), as one of the most common urological malignancies, has many histologic and molecular subtypes, among which clear cell renal cell carcinoma (ccRCC) is one of the most common causes of tumor-related deaths. However, the molecular mechanism of ccRCC remains unclear. In order to identify the candidate genes that may exist in the occurrence and development of ccRCC, microarray datasets GSE6344, GSE16441, GSE36895, GSE53757 and GSE76351 had been downloaded from Gene Expression Omnibus (GEO) database. Apart from that, the differentially expressed genes (DEGs) were screened through Bioinformatics & Evolutionary Genomics. In addition, the protein-protein interaction network (PPI) was constructed, and the module analysis was performed using STRING and Cytoscape. By virtue of DAVID online database, GO/KEGG enrichment analysis of DEGs was performed. Consequently, a total of 118 DEGs were screened, including 24 up-regulated genes and 94 down-regulated genes. The plug-in MCODE of Cytoscape was adopted to analyze the most significant modules of DEGs. What’s more, the genes with degree greater than 10 in DEGs were selected as the hub genes. The overall survival (OS) and disease progression free survival (DFS) of 9 hub genes were analyzed through GEPIA2 online platform. As shown by the survival analysis, SLC34A1, SLC12A3, SLC12A1, PLG, and ENO2 were closely related to the OS of ccRCC, whereas SLC34A1 and LOX were closely related to DFS. Among 11 SLC members, 6 SLC members were highly expressed in non-cancerous tissues (SLC5A2, SLC12A1, SLC12A3, SLC34A1, SLC34A2, SLC34A3). Besides, SLC12A5 and SLC12A7 were highly expressed in ccRCC. Furthermore, SLC12A1-A7, SLC34A1 and SLC34A3 were closely related to OS, whereas SLC12A2/A4/A6/A7 and SLC34A1/A3 were closely related to DFS. In addition, 5 algorithms were used to analyze hub genes, the overlapping genes were AQP2 and KCNJ1. To sum up, hub gene can help us understand the molecular mechanism of the occurrence and development of ccRCC, thereby providing a theoretical basis for the diagnosis and targeted therapy of ccRCC. Frontiers Media S.A. 2022-10-13 /pmc/articles/PMC9606658/ /pubmed/36313709 http://dx.doi.org/10.3389/fonc.2022.963483 Text en Copyright © 2022 Peng, Cao, Wang, Fang, Yan, Xia, Wang and Bi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Peng, Longfei
Cao, Zhangjun
Wang, Qi
Fang, Lu
Yan, Songbai
Xia, Dian
Wang, Jinyou
Bi, Liangkuan
Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title_full Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title_fullStr Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title_full_unstemmed Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title_short Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
title_sort screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: evidence from bioinformatic analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606658/
https://www.ncbi.nlm.nih.gov/pubmed/36313709
http://dx.doi.org/10.3389/fonc.2022.963483
work_keys_str_mv AT penglongfei screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT caozhangjun screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT wangqi screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT fanglu screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT yansongbai screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT xiadian screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT wangjinyou screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis
AT biliangkuan screeningofpossiblebiomarkersandtherapeutictargetsinkidneyrenalclearcellcarcinomaevidencefrombioinformaticanalysis